A Rev-independent human immunodeficiency virus type 1 (HIV-1)-based vector that exploits a codon-optimized HIV-1 gag-pol gene

Journal of Virology

Volumn 74, Issue 10, 2000, Pages 4839-4852

  Kotsopoulou, Ekaterini ^a   V Narry, Kim ^a   Kingsman, Alan J ^a,b   Kingsman, Susan M ^a,b   Mitrophanous, Kyriacos A ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b OXFORD BIOMEDICA UK LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ARTICLE; CODON; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRUS EXPRESSION; VIRUS GENE; VIRUS GENOME;

BASE SEQUENCE; CELL LINE; CELL NUCLEUS; CODON; CYTOPLASM; FUSION PROTEINS, GAG-POL; GENE EXPRESSION; GENES, ENV; GENES, GAG; GENES, POL; GENETIC VECTORS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSDUCTION, GENETIC; TRANSFECTION;

EID: 0342699700     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.10.4839-4852.2000     Document Type: Article

References (75)

1. Adachi, A., H. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M. Martin. 1986. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:284-291.
2. Afonina, E., M. Neumann, and G. Pavlakis. 1997. Preferential binding of poly(A)-binding protein I to an inhibitory RNA element in the HIV-1 gag mRNA. J. Biol. Chem. 272:2307-2311.
3. Andre, S., B. Seed, J. Eberle, W. Schraut, A. Bultmann, and J. Haas. 1998. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J. Virol. 72:1497-1503.
4. Arai, T., M. Takada, M. Ui, and H. Iba. 1999. Dose-dependent transduction of vesicular stomatitis virus G protein-pseudotyped retrovirus vector into human solid tumor cell lines and murine fibroblasts. Virology 260:109-115.
5. Arrigo, S. J., and I. S. Chen. 1991. Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs. Genes Dev. 5:808-819.
6. Barker, G. F., and K. Beemon. 1991. Nonsense codons within the Rous sarcoma virus gag gene decrease the stability of unspliced viral RNA. Mol. Cell. Biol. 11:2760-2768.
7. Berg, O., and C. Kurland. 1997. Growth-rate optimised tRNA abundance and codon usage. J. Mol. Biol. 270:1705-1711.
8. Blomer, U., L. Naldini, T. Kafri, D. Trono, I. M. Verma, and F. H. Gage. 1997. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71:6641-6649.
9. Brighty, D., and M. Rosenberg. 1994. A cis-acting repressive sequence that overlaps the Rev responsive element of HIV-1 regulates nuclear retention of env mRNAs independently of known splice signals. Proc. Natl. Acad. Sci. USA 91:8314-8318.
10. Cassan, M., N. Delaunay, C. Vaquero, and J. P. Rousset. 1994. Translational frameshifting at the gag-pol junction of human immunodeficiency virus type 1 is not increased in infected T-lymphoid cells. J. Virol. 68:1501-1508.
11. Chang, D. D., and P. A. Sharp. 1989. Regulation by HIV Rev depends upon recognition of splice sites. Cell 59:789-795.
12. Chang, L.-J., V. Urlacher, T. Iwakama, Y. Cui, and J. Zucali. 1999. Efficacy and safety analysis of a recombinant HIV-1 derived vector system. Gene Ther. 6:715-728.
13. Cimarelli, A., and J. Luban. 1999. Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 73:5388-5401.
14. Cui, Y., T. Iwakama, and L.-J. Chang. 1999. Contribution of viral splice sites and cis regulatory elements to lentivirus vector function. J. Virol. 73:6171-6176.
15. D'Agostino, D. M., B. K. Felber, J. E. Harrison, and G. N. Pavlakis. 1992. The Rev protein of human immunodeficiency virus type 1 promotes polysomal association and translation of gag/pol and vpu/env mRNAs. Mol. Cell. Biol. 12:1375-1386.
16. DuBridge, R. B., P. Tang, H. C. Hsia, P.-M. Leong, J. H. Miller, and M. P. Calos. 1987. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol. Cell. Biol. 7:379-387.
17. Dull, T., R. Zufferey, M. Kelly, R. Mandel, M. Nguyen, D. Trono, and L. Naldini. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463-8471.
18. Favaro, J., F. Maldarelli, S. Arrigo, and M. Schmidt. 1999. Effect of Rev on the cytoplasmic localization of intron-containing HIV-1 RNA. Virology 255: 237-249.
19. Felber, B. K., M. Hadzopoulou Cladaras, C. Cladaras, T. Copeland, and G. N. Pavlakis. 1989. Rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral messenger RNA. Proc. Natl. Acad. Sci. USA 86:1495-1499.
20. Fisher, A., E. Collalti, L. Ratner, R. Gallo, and F. Wong-Staal. 1985 A molecular clone of HTLV-III with biological activity. Nature 316:262-265.
21. Fornerod, M., M. Ohno, M. Yoshida, and I. W. Mattaj. 1997. CRM1 is an export receptor for leucine-rich nuclear export signals. Cell 90:1051-1060.
22. Fridell, R. A., H. P. Bogerd, and B. R. Cullen. 1996. Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. Proc. Natl. Acad, Sci. USA 93:4421-4424.
23. Gasmi, M., J. Glynn, M.-J. Jin, D. Jolly, J.-K. Yee, and S.-T. Chen. 1999. Requirements for efficient production and transduction of human immunodeficiency virus type 1-based vectors. J. Virol. 73:1828-1834.
24. Haas, J., E.-C. Park, and B. Seed. 1996. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 6:315.
25. Hadzopoulou Cladaras, M., B. K. Felber, C. Cladaras, A. Athanassopoulos, A. Tse, and G. N. Pavlakis. 1989. The rev (trs/art) protein of human immunodeficiency virus type 1 affects viral mRNA and protein expression via a cis-acting sequence in the env region. J. Virol. 63:1265-1274.
26. Harrison, G., G. Miele, E. Hunter, and A. Lever. 1998. Functional analysis of the core human immunodeficiency virus type 1 packaging signal in a permissive cell line. J. Virol. 72:5886-5896.
27. Hentze, M., and A. Kulozik. 1999. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 96:307-310.
28. Huang, Y., and G. Carmichael. 1997. The mouse histone H2a gene contains a small element that facilitates cytoplasmic accumulation of intronless gene transcripts and of unspliced HIV-1 related mRNAs. Proc. Natl. Acad. Sci. USA 94:10104-10109.
29. Jacks, T., M. D. Power, F. R. Masiarz, P. A. Luciw, P. J. Barr, and H. E. Varmus. 1988. Characterization of ribosomal frameshifting in HIV-1 gag-pol expression. Nature 331:280-283.
30. Kim, S. Y., R. Byrn, J. Groopman, and D. Baltimore. 1989. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 63:3708-3713.
31. Kim, V. N., K. Mitrophanous, S. M. Kingsman, and A. J. Kingsman. 1998. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72:811-816.
32. Kozak, M. 1992. Regulation of translation in eukaryotic systems. Annu. Rev. Cell Biol. 8:197-225.
33. Kypr, J., and J. Mrazek. 1987. Unusual codon usage of HIV. Nature 327:20.
34. Kypr, J., J. Mrazek, and J. Reich. 1989. Nucleotide composition bias and CpG dinucleotide content in the genomes of HIV and HTLV 1 and 2. Biochim. Biophys. Acta 1009:280-282.
35. Lever, A., H. Gottlinger, W. Haseltine, and J. Sodroski. 1989 Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 63:4085-4087.
36. Maldarelli, F., M. A. Martin, and K. Strebel. 1991. Identification of posttranscriplionally active inhibitory sequences in human immunodeficiency virus type 1 RNA: novel level of gene regulation. J. Virol. 65:5732-5743.
37. Malim, M. H., and B. R. Cullen. 1993. Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol. Cell. Biol. 13:6180-6189.
38. Malim, M. H., J. Hauber, S. Y. Le, J. V. Maizel, and B. R. Cullen. 1989. The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature 338:254-257.
39. Maurer, F., M. Tierney, and R. Medcalff. 1999. An AU-rich sequence in the 3' UTR of PAI-2 mRNA promotes PAI-2 mRNA decay and provides a binding site for nuclear HuR. Nucleic Acids Res. 27:1664-1673.
40. McBride, M. S., and A. T. Panganiban. 1997. Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo. J. Virol. 71:2050-2058.
41. Medappa, K. C., C. McLean, and R. R. Rueckert. 1971. On the structure of rhinovirus IA. Virology 44:259-270.
42. Mikaelian, I., M. Krieg, M. Gait, and J. Karn. 1996. Interactions of INS (CRS) elements and the splicing machinery regulate the production of Rev-responsive mRNAs. J. Mol. Biol. 257:246-264.
43. Naldini, L. 1998. Lentiviruses as gene transfer agents for delivery to nondividing cells. Curr. Opin. Biotechnol. 9:457-463.
44. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
45. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells hy a lentiviral vector. Science 272:263-267.
46. Nasioulas, G., A. S. Zolotukhin, C. Tabernero, L. Solomin, C. P. Cunningham, G. N. Parlakis, and B. K. Felber. 1994. Elements distinct from human immunodeficiency virus type 1 splice sites are responsible for the Rev dependence of env mRNA. J. Virol. 68:2986-2993.
47. Olsen, H., A. Cochrane, and C. Rosen. 1992. Interaction of cellular factors with intragenic cis-acting repressive sequences within the HIV genome. Virology 191:709-715.
48. Otero, G. C., M. E. Harris, J. E. Donello, and T. J. Hope. 1998 Leptomycin B inhibits equine infectious anemia virus Rev and feline immunodeficiency virus rev function but not the function of the hepatitis B virus posttranscriptional regulatory element. J. Virol. 72:7593-7597.
49. Parkin, N. T., M. Chamorro, and H. E. Varmus. 1992. Human immunodeficiency virus type 1 gag-pol frameshifting is dependent on downstream mRNA secondary structure: demonstration by expression in vivo. J. Virol. 66:5147-5151.
50. Parolin, C., T. Dorfman, G. Palu, H. Gottlinger, and J. Sodroski. 1994. Analysis in human immunodeficiency virus type I vectors of cis-acting sequences that affect gene transfer into human lymphocytes. J. Virol. 68:3888-3895.
51. Pollard, V., and M. Malim. 1998. The HIV-1 Rev protein. Annu. Rev. Microbiol. 52:491-532.
52. Qiu, J.-T., R. Song, M. Dettenhofer, C. Tian, T. August, B. Felber, G. Pavlakis, and X.-F. Yu. 1999. Evaluation of novel human immunodeficiency virus type 1 Gag DNA vaccines for protein expression in mammalian cells and induction of immune responses. J. Virol. 73:9145-9152.
53. Rabbits, P., A. Forster, M. Stinson, and T. Rabbits. 1985. Truncation of exon 1 from the c-myc gene results in prolongued c-myc mRNA stability. EMBO J. 4:3727-3733.
54. Rouwendal, G. J., O. Mendes, E. J. Wolbert, and A. Douwe de Boer. 1997. Enhanced expression in tobacco of the gene encoding green fluorescent protein by modification of its codon usage. Plant Mol. Biol. 33:989-999.
55. Sagerstrom, C., and H. Sive. 1996. RNA blot analysis, p. 83-104. In P. Krieg (ed.). A laboratory guide to RNA: isolation, analysis and synthesis, vol. 1. Wiley-Liss Inc., New York, N.Y.
56. Schneider, R., M. Campbell, G. Nasioulas, B. K. Felber, and G. N. Pavlakis. 1997. Inactivation of the human immunodeficiency virus type 1 inhibitory elements allows Rev-independent expression of Gag and Gag/protease and particle formation. J. Virol. 71:4892-4903.
57. Schwartz, S., M. Campbell, G. Nasioulas, J. Harrison, B. K. Felber, and G. N. Pavlakis. 1992. Mutational inactivation of an inhibitory sequence in human immunodeficiency virus type 1 results in Rev-independent gag expression. J. Virol. 66:7176-7182.
58. Schwartz, S., B. K. Felber, and G. N. Pavlakis. 1992. Distinct RNA sequences in the gag region of human immunodeficiency virus type 1 decrease RNA stability and inhibit expression in the absence of Rev protein. J. Virol. 66:150-159.
59. Sharp, P. M. 1986. What can AIDS virus codon usage tell us? Nature 324:114.
60. Soneoka, Y., P. M. Cannon, E. E. Ramsdale, J. C. Griffiths, G. Romano, S. M. Kingsman, and A. J. Kingsman. 1995. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 23:628-633.
61. Sostengard, T., and P. Hackett. 1996. Autogenous regulation of RNA translation and packaging by Rous sarcoma virus Pr76Gag. J. Virol. 70:6642-6652.
62. Stade, K., C. S. Ford, C. Guthrie, and K. Weis. 1997. Exportin 1 (Crm1p) is an essential nuclear export factor. Cell 90:1041-1050.
63. Ullman, K. S., M. A. Powers, and D. J. Forbes. 1997. Nuclear export receptors: from importin to exportin. Cell 90:967-970.
64. van Hemert, F. J., and B. Berkhout. 1995. The tendency of lentiviral open reading frames to become A-rich: constraints imposed by viral genome organization and cellular tRNA availability. J. Mol. Evol. 41:132-140.
65. Varenne, S., J. Buc, R. Lloubes, and C. Lazdunski. 1984 Translation is a nonuniform process: effect of transfer RNA availability on the rate of elongation of nascent polypeptide chains. J. Mol. Biol. 180:549-576.
66. Verma, I. M., and N. Somia. 1997. Gene therapy-promises, problems and prospects. Nature 389:239-242.
67. Wilson, S., C. Sieiro-Vasquez, N. Edwards, O. Iourin, E. Byles, E. Kotsopoulou, C. Adamson, S. Kingsman, A. Kingsman, and E. Martin-Rendon. 1999. Cloning and characterisation of hIF2, a human homologue of bacterial translation initiation factor 2, and its interaction with HIV-1 matrix. Biochem. J. 342:97-103.
68. Wilson, W., M. Braddock, S. E. Adams, P. D. Rathjen, S. M. Kingsman, and A. J. Kingsman. 1988. HIV expression strategies: ribosomal frameshifting is directed by a short sequence in both mammalian and yeast systems. Cell 55:1159-1169.
69. Wisdom, R., and W. Lee. 1991. The protein coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitors. Genes Dev. 5:232-243.
70. Wolff, B., J.-J. Sanglier, and Y. Wang. 1997. Leptomycin B is an inhibitor of nuclear export: inhibition of nucleocytoplasmic translocation of the HIV-1 Rev protein and Rev-dependent mRNA. Chem. Biol. 4:139-147.
71. Xu, N., C.-Y. Chen, and A.-B. Shyu. 1997. Modulation of the fate of cytoplasmic mRNA by AU-rich elements: key sequence features controlling mRNA deadenylation and decay. Mol. Cell. Biol. 17:4611-4621.
72. Yang, T. T., L. Cheng, and S. R. Kain. 1996. Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res. 24:4592-4593.
73. Yee, J. K., A. Miyanohara, P. LaPorte, K. Bouic, J. C. Burns, and T. Friedmann. 1994. A general method for the generation of high-liter, pantropic retroviral vectors: highly efficient infection of primary hepatocytes. Proc. Natl. Acad. Sci. USA 91:9564-9568.
74. Zolotukhin, A. S., A. Valentin, G. N. Pavlakis, and B. K. Felber. 1994. Continuous propagation of RRE(-) and Rev(-)RRE(-) human immunodeficiency virus type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J. Virol. 68:7944-7952.
75. Zolotukhin, S., M. Potter, W. W. Hauswirth, J. Guy, and N. Muzyczka. 1996. A "humanized" green fluorescent protein cDNA adapted for high-level expression in mammalian cells. J. Virol. 70:4646-4654.